APA (7th ed.) Citation

YH, C., BA, H., JP, S., D, B., C, S., KD, M., & M, R. (2017). Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy. NPJ breast cancer, 3, 24. https://doi.org/10.1038/s41523-017-0028-4

Chicago Style (17th ed.) Citation

YH, Chen, Hancock BA, Solzak JP, Brinza D, Scafe C, Miller KD, and Radovich M. "Next-generation Sequencing of Circulating Tumor DNA to Predict Recurrence in Triple-negative Breast Cancer Patients with Residual Disease After Neoadjuvant Chemotherapy." NPJ Breast Cancer 3 (2017): 24. https://doi.org/10.1038/s41523-017-0028-4.

MLA (9th ed.) Citation

YH, Chen, et al. "Next-generation Sequencing of Circulating Tumor DNA to Predict Recurrence in Triple-negative Breast Cancer Patients with Residual Disease After Neoadjuvant Chemotherapy." NPJ Breast Cancer, vol. 3, 2017, p. 24, https://doi.org/10.1038/s41523-017-0028-4.